Integrated Treatment Program for Hypochondriasis in Primary Care Settings

Completed · Phase 3

Conditions studied: Hypochondriasis, Somatoform Disorders

In brief

This study will evaluate the effectiveness of an integrated three-part treatment program in improving the quality of care and treatment outcomes of people with hypochondriasis in primary care settings.

Key facts

Study ID: NCT00368212
Run by: Brigham and Women's Hospital
People needed: 91
Starts: 2005-05-01
Expected to finish: 2008-07-01
Last updated by the study team: 2013-03-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Has received primary medical care at Harvard Vanguard Medical Associates (HVMA) for at least 12 months prior to study entry
Expects to continue receiving care from the current primary care physician for at least the next 12 months
Meets requirement for average hypochondriasis screening score
Able to speak and read English
Falls within the top 20% of utilizers of health care services in the HVMA system over the past year
Has attended no more than one visit to any specialist over the year prior to study entry

You may not qualify if…

Psychiatric illness (e.g., psychosis, dementia, suicidal ideation)
Somatoform pain disorder or currently receiving treatment for somatoform pain disorder (e.g., relaxation training)
History of alcohol or substance abuse or dependence within the 12 months prior to study entry
Terminal medical illness or major medical illness expected to worsen significantly over the next year
Ongoing symptom-contingent litigation against HVMA
Monetary compensation for medical disability

Where it is running

Harvard Vanguard Medical Associates — Boston, Massachusetts, United States
Harvard Vanguard Medical Associates — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.